Budesonide, prolonged release tablets, 9 mg product- specific bioequivalence guidance

HumanScientific guidelines

This document provides product-specific guidance on the demonstration of budesonide, prolonged release tablets, 9 mg product-specific bioequivalence guidance.

Keywords: Bioequivalence, generics, budesonide

 

Current version

Budesonide, prolonged release tablets, 9 mg product- specific bioequivalence guidance

AdoptedReference Number: EMA/CHMP/219378/2024Legal effective date:

English (EN) (140.88 KB - PDF)

First published:
View

Document history

Budesonide, prolonged release tablets, 9 mg product-specific bioequivalence guidance

Draft: consultation closedConsultation dates: to Reference Number: EMA/CHMP/219378/2024Summary:

Comments should be provided using this EUSurvey form . For any technical issues, please contact the EUSurvey Support.

English (EN) (158.87 KB - PDF)

First published:
View

Share this page

Back to top